Our researchers, who come from institutions across the United States and around the world, are all committed to improving the lives of patients with ovarian cancer. To view all current and past grantees and their projects, search by institution, research focus, grantee name, or year awarded.

Collaborative Research Development Grant

Launched in 2004, this grant provides funds for large ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple institutions. Support of $300,000 annually for three years will be awarded to the institution(s) in which the recipients will conduct the research.

View Collaborative Research Development Grant recipients

Early Career Investigator Grant

(Formerly Liz Tilberis Early Career Award) Launched in December 2000, the Early Career Investigator Grant is for junior faculty (Assistant Professor level) with a strong commitment to an investigative career in ovarian cancer research. Each grantee will receive a three-year grant of $150,000 per year.

View Early Career Investigator Grant recipients

Mentored Investigator Grant

(Formerly Ann and Sol Schreiber Mentored Investigator Award) The Mentored Investigator Grant provides funding for trainees (post-doctoral fellows or clinical fellows) who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research. Applicants must have an MD or a PhD degree. The grant provides a total of $75,000 to be used over one or two years, and will encourage the recipient’s research career in the field of ovarian cancer.

View Mentored Investigator Grant recipients

Individual Investigator Award

From 1998 – 2007, OCRF offered Individual Investigator Awards to advance outstanding early career researchers whose projects focused on early detection, screening, and basic translational research. These $100,000 grants were intended to yield results within two years or less. The ultimate aim of the program was to enable investigators, with promising results in hand, to obtain grants from the National Cancer Institute or other large funding agencies.

View Individual Investigator Award recipients

Meet Some of our Researchers

Anne van Harten, PhD

Dr. Anne van Harten, of the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia, is designing and testing a new compound to target a protein that is essential to ovarian cancer development, with the aim of finding a new targeted therapy for high-grade serous ovarian cancer patients.

Sohrab Shah, PhD

Dr. Shah is leading a computational oncology program at Memorial Sloan Kettering, making biological imprints from all data collected from cancer patients to encourage scientific collaboration, analysis and progress toward a cure.

Sridevi Challa, PhD

Dr. Sridevi Challa, of UT Southwestern, is examining ovarian cancer cell growth on a molecular level, investigating how certain proteins can be manipulated to kill tumor cells.